Insights from SARS-CoV-2 nanopore genomic surveillance in Edo State, Nigeria
This study demonstrates how leveraging pre-existing Lassa fever laboratory capacity at Irrua Specialist Teaching Hospital in Edo State, Nigeria, enabled successful SARS-CoV-2 nanopore genomic surveillance that tracked the country's dual role as both a source and recipient of viral lineages during the pandemic.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
When a virus spreads through a population, it leaves behind a trail of genetic changes, much like a fingerprint that shifts slightly with every new infection. Scientists can read these changes to trace where a virus came from, how it moved between places, and which versions are becoming dominant. This practice, known as genomic surveillance, is crucial for understanding how diseases evolve and spread, especially in regions where resources for testing are scarce. For years, many parts of the world lacked the tools to perform this kind of deep genetic reading, leaving a blind spot in the global effort to track outbreaks. The story of how a hospital in Nigeria turned this situation around offers a clear look at how local expertise can be adapted to fight a new global threat, revealing not just how a virus moved, but how the people who study it can move with it.
In Edo State, Nigeria, the Irrua Specialist Teaching Hospital has long been a center for studying Lassa fever, a dangerous viral disease found in the region. Because of this history, the hospital already had staff trained to use a specific type of genetic sequencing technology called nanopore sequencing. This method allows scientists to read the genetic code of a virus directly from a sample, quickly identifying its family and tracking its mutations. When the SARS-CoV-2 virus arrived, the hospital was ready to pivot. Instead of waiting for outside help, they used their existing skills and equipment to build a new lab dedicated to sequencing the coronavirus. Between 2020 and 2023, the hospital tested nearly 30,000 people for the virus, finding positive cases in about 15 percent of them. While the hospital had been testing for years, the ability to sequence the virus's genome to see exactly which variant was present was only fully established in 2022, after a team of local staff received intensive training in Guinea and Germany.
Once the sequencing lab was running, the team looked back at samples collected over the previous two years to see what they could learn. They successfully generated nearly 200 high-quality viral genomes from samples taken between April and December 2022. These genetic snapshots told a story of movement that was more complex than a simple one-way street. The analysis showed that Nigeria played a dual role in the global spread of the virus. For the Delta variant, which dominated in 2021, Nigeria acted as a major source. The genetic evidence suggests that a specific version of the Delta virus, known as AY.36, originated or became established in Nigeria and then spread out to Europe, North America, and other parts of the world. The data indicates that this export of the virus happened as early as late March 2021, with the virus traveling from Nigeria to Europe and then to other continents.
However, the story changed as the pandemic evolved. When the Omicron variant arrived, the flow of the virus reversed. The genetic analysis suggests that the Omicron sub-lineages found in Nigeria, specifically BA.1.1 and BQ.1, were not born there. Instead, they were imported from other parts of the world. The BA.1.1 version likely arrived from North America, while the BQ.1 version came from Europe. Once these new versions entered Nigeria, they did not just sit there; they spread rapidly within the country and then moved back out to other regions, including Europe and Asia. This pattern highlights that while Nigeria was a hub for sending out the Delta variant, it also served as a receiving point for later waves of the virus, acting as a bridge that connected different parts of the world.
The success of this project was not just about the data it produced, but about how it was achieved. The researchers demonstrated that a laboratory built to fight one high-risk pathogen, Lassa fever, could be effectively repurposed to track a new one, SARS-CoV-2, without starting from scratch. By training local staff in both the lab work and the computer analysis needed to interpret the genetic data, the team created a self-sustaining system. This approach allowed them to generate insights that would have been impossible if they had relied solely on international labs. The work confirms that building local capacity in low-resource settings is not only possible but essential for understanding how viruses move across borders. It shows that when a region has the tools to read the genetic code of a virus, it can reveal the hidden pathways of an outbreak, turning a local effort into a vital piece of the global puzzle.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.